Wendy Bannister - Concepedia

Author

Wendy Bannister

Also Known As

A Cozzi Lepri, A Cozzi-Lepri, A. Cozzi-Lepri, D Byonanebye, E Tusch, K K Andersen, Matthijs van Luin, W Bannister, W. Bannister, Wendy Bannister

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University College London Rigshospitalet AstraZeneca (United Kingdom)University of Copenhagen The Royal Free Hospital

About

Wendy Bannister is an author at University College London specializing in medicine, pharmacotherapy, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	366
2	Public Health	1	1	43
3	Epidemiology	1	1	43
4	Nephrology	1	1	29
5	Nutrition	1	1	44

Wendy Bannister

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Assisted reproductive therapies and imprinting disorders—a preliminary British survey Alastair Sutcliffe, Catherine Peters, Sarah Bowdin, Human Reproduction	2005	254
The Coding Causes of Death in HIV (CoDe) Project Justyna Kowalska, Nina Friis‐Møller, Ole Kirk, Epidemiology	2011	142
An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib Joaquı́n Mateo, Víctor Moreno, Avinash Gupta, Targeted Oncology Parp Inhibitor OlaparibPharmacological StudyMedicineTablet FormulationPharmacotherapy	2016	126
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial Mark E. Robson, Kathryn J. Ruddy, Seock‐Ah Im, European Journal of Cancer	2019	84
Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies Luc Dirix, Helen Swaisland, Henk M.W. Verheul, Clinical Therapeutics OncologyMedicineAdvanced Solid TumorsClinical PharmacologyPharmacotherapy	2016	56
Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours Ruth Plummer, Helen Swaisland, Karin Leunen, Cancer Chemotherapy and Pharmacology Olaparib Tablet FormulationOncologyMedicineAdvanced Solid TumoursOral Dosing	2015	51
Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study Wendy Bannister, Alessandro Cozzi‐Lepri, Bonaventura Clotet, JAIDS Journal of Acquired Immune Deficiency Syndromes	2008	49
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA Wendy Bannister, Alessandro Cozzi‐Lepri, Amanda Mocroft, AIDS	2008	48
Effect of Food on the Pharmacokinetics of Olaparib after Oral Dosing of the Capsule Formulation in Patients with Advanced Solid Tumors Christian Rolfo, Helen Swaisland, Karin Leunen, Advances in Therapy NutritionOncologyMedicineAdvanced Solid TumorsCapsule Formulation	2015	44
Independent effects of the −219 G>T and ε2/ε3/ε4 polymorphisms in the apolipoprotein E gene on coronary artery disease: The Southampton Atherosclerosis Study Shu Ye, Louise Dunleavey, Wendy Bannister, European Journal of Human Genetics −219 GEpidemiologyGenetic DeterminantCardiovascular EpidemiologyCardiovascular Disease	2003	43

Page 1